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Background: Transcranial direct current stimulation (tDCS) of prefrontal cortex regions has been re-
ported to exert antidepressant effects, though large scale multicenter trials in major depressive disorder
(MDD) supporting this notion are still lacking. Application of tDCS in multicenter settings, however,
requires measurement, storage and evaluation of technical parameters of tDCS sessions not only for
safety reasons but also for quality control. To address this issue, we conducted an interim analysis of
supervised technical data across study centers in order to monitor technical quality of tDCS in an ongoing
multicenter RCT in MDD (DepressionDC trial).
Methods: Technical data of 818 active tDCS sessions were recorded, stored in a data cloud, and analysed
without violating study blinding. Impedance, voltage and current were monitored continuously with one
data point recorded every second of stimulation.
Results: Variability of impedance was considerable (1,42 kU, to 8,23 kU), inter-individually and even
more intra-individually, but did not significantly differ between the study centre in Munich and all other
sites.
Conclusion: Measurement, centralized data storage via data cloud and remote supervision of technical
parameters of tDCS are feasible and proposed for future RCTs on therapeutic tDCS in multiple settings.
© 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Dear Editor,1. Introduction
Transcranial direct current stimulation (tDCS), a form of low in-
tensity transcranial electrical stimulation (tES), is a promising ther-
apeutic tool for the treatment of neurological [1] and psychiatric
disorders [2e4]. Due to its beneficial safety profile, cost-
effectiveness and suitability for clinical use, including home treat-
ment, tDCS applications are spreading rapidly [5]. However, data
on efficacy, stimulation quality and safety are limited due to a
lack of large multicenter randomized controlled trials (RCTs). For
both, multicenter trials, but also future clinical application of
tDCS across settings including home treatment, monitoring of tech-
nical parameters (i.e. impedance or current) is essential to maintain
technical standards, judge on compliance, and potentially to in-
crease the likelihood of response. Here we present a blind interim
analysis of technical parameters in 818 active tDCS sessions from
an ongoing multicenter RCT in MDD [2] investigating the efficacy
and safety of prefrontal tDCS used in addition to a stable antide-
pressant medication with selective serotonin reuptake inhibitors
(SSRI).Inc. This is an open access article u2. Methods
The DepressionDC Trial (trial registration at ClinicalTrials.gov:
NCT02530164) started in 2015 and is currently in its final phase
as the last patient has completed the follow-up phase in January
2021. The study has been carried out in accordance with the Decla-
ration of Helsinki. Informed consent was obtained prior to any
study related procedure. Technical data which did not contain
any link to a patient identification number of 41 patients were pro-
vided by six study sites: LMU Munich (n ¼ 20), Charite Berlin, Uni-
versity of Tübingen, University of Regensburg, University of
Freiburg, Isar-Amper-Klinikum Wasserburg.2.1. Stimulation procedure
Eligible patients were respectively assigned to 24 sessions active
or sham tDCS as an add-on to stable SSRI medication, to which pa-
tients had not sufficiently responded yet. Patients in both groups
received 5 daily tDCS sessions per week for 4 weeks, followed by
2 weeks consisting of 2 treatment sessions per week. tDCS was con-
ducted as previously reported [2]. In brief, a pre-programmed
portable stimulation device was used at an intensity of 2 mA with
a bifrontal montage of 35 cm2 saline soaked sponge electrodesnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tem was used for standardized electrode positioning. Each session
lasted 30 min plus 15 sec ramp-in at the beginning and 30 sec
ramp-out at the end. Sham condition is described in more detail
in the published study protocol [2].2.2. Technical data
With a sampling rate of one per sec. the stimulator continuously
measured the applied current (I) and the adjusted voltage (U),
which reflects many non-linear processes at both, electrodes and
the tissue. These processes determine the impedance according
to Ohm's law (R ¼ U/I). For measurement of very low
currents < 150mA during early ramp-in and late ramp-out periods,
an implemented correction mechanism considered the non-
proportional interdependency between current and voltage in
lower current levels: If the measured current I was lower than a
threshold T, a correction factor C was calculated depending on
the difference between T and I and an empirically determined
parameter E. The electrode impedance Z for currents lower than
threshold T was calculated using the measured voltage V and the
measured current I, scaled by the correction factor.
Data were saved on the connected saving tool and automatically
transferred via data cloud solution provided by neuroConn Ilmenau
to a validated study database implemented by the Münchner Stud-
ienzentrum (MSZ), whichmonitors the principles of ICH Good Clin-
ical Practice and controls the trial conduct. To prevent unblinding
the MSZ randomly selected only 20 sessions of active tDCS per pa-
tient. The selection followed the criteria, that all patients who
received active stimulation and at least 20 tDCS sessions were
selected without exception, From patients with more than 20 ses-
sions (i.e. up to possible 24 sessions during the treatment phase),
only 20 sessions were randomly selected to prevent unblinding
by individually revealing the exact number of tDCS sessions. NoFig. 1. Distribution of variability in impedance observed in tDCS sessions by subjects (20 s
distance between two sessions. Boxes represent 25th to 75th percentile with the black bar
1235further criteria were applied, and both data selection and analysis
were kept fully separate from the ongoing trial and study
personnel. In each session, technical data of 1844 measurement
points were recorded. In two patients, data of only 19 sessions
were conducted and used for further analysis.2.3. Statistical analyses
For further analyses, we excluded ramp-in and ramp-out pe-
riods because within such start and shut down intervals, current
changes are intended and higher impedance levels are expected
to occur. Ramp-in and ramp-out phases were not part of the regular
active tDCS session of 30 minutes, but came in addition. The data
were evaluated using the open source software “R 3.5.2”. In order
to analyse the variability across measurements, we estimated the
similarity between all sequences of measures within each partici-
pant using dynamic time warping (DTW) as implemented in the
“dtw” package. This algorithm estimates the similarity of two se-
quences by calculating the optimal match between them based
on certain restriction and rules (for more information on DTW
see Ref. [6]). The resulting scores indicated the variability across tri-
als clustered in participants, days, and study centers. Scores had a
minimum of zero indicating no variability across trials whereas
higher scores indicated higher variability.
3. Results
The tests for differences in the variability referred to imped-
ances between subjects, sessions and centers, where the analysis
of between-centers differences compared the main centre with
the other centers due to the better comparability of two similarly
sized samples. Considering the phase of the stimulations without
ramp-in and ramp-out, impedance minimum was 1,42 kU,
maximum 8,23 kU.essions per subject) and centers (Munich vs. Other). Each observation represents the
representing the median variability. Outliers are represented as black dots.
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used DTW as described above. 18 % of the variance in the measure-
ments was explained by inter-individual differences between sub-
jects (F[40,7673] ¼ 42.34; p < .001; h2 ¼ 0.18). However, the major
portion of the variance was observed in intra-individual differences
across trials. There were no significant differences between the
study centre in Munich which recruited about half of the patients
and the other centers regarding variability of the measured data
(F[1,7712] ¼ 1.80; p ¼ .180; h2 ¼ 0.00) and average impedance (F
[1,26] ¼ 1.42; p ¼ .245;. h2 ¼ 0.05) (Fig. 1).
Further data for impedance (i.e. mean impedances for individual
patients, Fig. S1) as well as current intensity including the distribu-
tion of variability (Fig. S2) are reported in the Supplementary
Material.
4. Discussion
The presented data show for the first time the course of the
technical parameters of tDCS in a multicenter study. 818 stimula-
tions with a total of 1,508,276 measurement points were consid-
ered. We present the course of the technical parameters as a
possible marker for the stimulation quality and were able to
show that online monitoring of technical parameters is feasible
and helpful for tDCS quality control. Our data show that variability
of impedance was considerable (1,42 kU, to 8,23 kU), but did not
significantly differ between the study centre in Munich and all
other sites. Current intensity (raw data) varied between 2.087 mA
and 1.875 mA, and there was a difference between centers with a
low effect size, which was significant due to the large number of
measurements. Nevertheless, there are several issues to be dis-
cussed. The first, impedance was calculated from measurements
of current and voltage with a formula that was used to correctly
map the “real” impedance values even in lower current ranges.
Non-linear relationships between current and voltage in relation
to the impedance in many areas can principally not be assessed
without errors in this way. The directmeasurement of the electrode
resistance, which largely contributes to impedance, could have
been done with the help of a test current and/or the use of a
sentinel electrode [7]. However, there are limitations regarding
large scale application, e.g. in multicenter RCTs. Another limitation
is that we have no previous data from our group nor data from
other sources, and to our knowledge, standards for objectively
quantifying the variation of technical parameters are lacking.
Thus, statements on our data meeting quality criteria would be pre-
mature, andwe just can compare the variation of technical tDCS pa-
rameters e.g. across study sites. We believe, however, that our
approach could be useful not only for monitoring tDCS quality in
various settings, but also for establishing quality standards and
ensuring reproducibility [8].
5. Conclusion
The approach in the DepressionDC study, i.e. the central collec-
tion and storage of the technical parameters on a data cloud, which
can be accessed centrally, was successfully tested in a first sample
of study participants. Our approach could leverage quality control
in multicenter RCTs on therapeutic tDCS for psychiatric or neuro-
logical disorders in various settings including home treatment.
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